Bani Tchekanova, Ph.D.

Bani Tchekanova PhD, was appointed Head of Regulatory Strategy and Operations of Armata in July 2025. Prior to joining Armata, Bani served as a Chief Principal Advisor at ClinReg Partners, LLC. Bani brings with her over 25 years of diverse and dynamic experience in global drug development and regulatory affairs. Her career spans a wide array of therapeutic areas, including infectious disease, oncology, dermatology, ophthalmology, cardiovascular, neuroscience, and gene therapy. From investigational INDs to full-scale BLA and NDA submissions, Bani has led strategy and execution across the entire lifecycle of regulatory development — always with a clear focus on patient needs and regulatory innovation.

She has served in executive leadership roles including Senior Vice President of Global Regulatory Affairs at HUYABIO and Vice President of Regulatory Affairs, Quality, Clinical, and Compliance at Collidion Inc. Notably, Bani currently serves as the Industry Representative on the FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology, a role that reflects her deep expertise and national recognition in the field. In addition to her professional accomplishments, Bani is an advocate and educator in applying Artificial Intelligence in drug development and regulatory operations.

Her educational background includes a Ph.D. in Health Administration, M.S. in Clinical Laboratory Sciences, and B.S. in Biology and Chemistry.